Doxycycline-Induced Autoimmune Hepatitis.

ACG Case Rep J

Division of Gastroenterology and Hepatology, The Warren Alpert Medical School of Brown University, Providence, RI.

Published: August 2020

Doxycycline and minocycline are tetracyclines with the potential to cause hepatoxicity. Although autoimmune-like hepatitis from minocycline is well-described, doxycycline-induced autoimmune hepatitis (DIAH) has only been described once. We report a rare case of DIAH with elevated liver enzymes over 5 times the normal upper limit, elevated immunoglobulin G, and high titers of antismooth muscle antibody and antinuclear antibody. By stopping doxycycline, our patient's liver enzymes normalized and immunoglobulin G and autoantibody titers rapidly downtrended. As long-term doxycycline therapy becomes more prevalent to treat acne vulgaris and other skin conditions, DIAH may become more prevalent and recognized.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7423905PMC
http://dx.doi.org/10.14309/crj.0000000000000440DOI Listing

Publication Analysis

Top Keywords

doxycycline-induced autoimmune
8
autoimmune hepatitis
8
liver enzymes
8
hepatitis doxycycline
4
doxycycline minocycline
4
minocycline tetracyclines
4
tetracyclines potential
4
potential hepatoxicity
4
hepatoxicity autoimmune-like
4
autoimmune-like hepatitis
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!